Medartis entered into an exclusive global distribution partnership with Field Orthopaedics. The strategic partnership will include the addition of the NX Nail system to Medartis’ comprehensive hand portfolio.
This alliance will enable Medartis to further leverage the NX Nail’s intraosseous, minimally invasive treatment options for fractures of the metacarpal and phalanx, and provide additional growth opportunities in the U.S. extremities market and potentially in additional markets.
The NX Nail is complementary to the Medartis plating systems and CCS screw portfolio. The role of this implant is to rigidly fix bone fragments in space while crossing the fracture to act as a strut. The NX Nail acts as a physiological splint, designed to withstand normal loads and to facilitate rapid return to normal activity. The company plans to begin distributing the products in 4Q22.
Ryan Schlotterback, Chief Technology Officer (US) for Medartis, commented. “The NX Nail system addresses the growing need of surgeons for an efficient, less invasive treatment that enables rapid recovery of patients after a finger fracture. NX Nail is the most comprehensive hand nailing system on the market and it perfectly complements our APTUS hand plate and screw portfolio.”
Patryk Kania, CEO Field Orthopaedics said, “By combining [Medartis’] global reach and commercial expertise with Field Orthopaedics’ innovative solutions for hand extremity trauma, we can rapidly extend our sales and distribution footprint, and ultimately reach more patients in more countries. It’s fantastic that two organizations driven by excellence and innovation can partner to provide the most comprehensive hand surgery offerings for surgeons and their patients.”
Medartis entered into an exclusive global distribution partnership with Field Orthopaedics. The strategic partnership will include the addition of the NX Nail system to Medartis’ comprehensive hand portfolio.
This alliance will enable Medartis to further leverage the NX Nail’s intraosseous, minimally invasive treatment options for fractures of...
Medartis entered into an exclusive global distribution partnership with Field Orthopaedics. The strategic partnership will include the addition of the NX Nail system to Medartis’ comprehensive hand portfolio.
This alliance will enable Medartis to further leverage the NX Nail’s intraosseous, minimally invasive treatment options for fractures of the metacarpal and phalanx, and provide additional growth opportunities in the U.S. extremities market and potentially in additional markets.
The NX Nail is complementary to the Medartis plating systems and CCS screw portfolio. The role of this implant is to rigidly fix bone fragments in space while crossing the fracture to act as a strut. The NX Nail acts as a physiological splint, designed to withstand normal loads and to facilitate rapid return to normal activity. The company plans to begin distributing the products in 4Q22.
Ryan Schlotterback, Chief Technology Officer (US) for Medartis, commented. “The NX Nail system addresses the growing need of surgeons for an efficient, less invasive treatment that enables rapid recovery of patients after a finger fracture. NX Nail is the most comprehensive hand nailing system on the market and it perfectly complements our APTUS hand plate and screw portfolio.”
Patryk Kania, CEO Field Orthopaedics said, “By combining [Medartis’] global reach and commercial expertise with Field Orthopaedics’ innovative solutions for hand extremity trauma, we can rapidly extend our sales and distribution footprint, and ultimately reach more patients in more countries. It’s fantastic that two organizations driven by excellence and innovation can partner to provide the most comprehensive hand surgery offerings for surgeons and their patients.”
Copy to clipboard 
